COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,973 Articles (22,604 medRxiv, 8,369 bioRxiv)

Most recent first Previous |  Page 101: Articles 1001-1010  | Next

Impacts of the COVID-19 pandemic on antibiotic use and resistance in hospitals: a retrospective ecological analysis of French national surveillance data over 2019-2022
Layan, M., Smith, D. R. M., Kerneis, S., Simon, L., Dumartin, C., Dugravot, L., Jouzeau, A., Maugat, S., Gambotti, L., Watier, L., Opatowski, L., Temime, L.
10.1101/2024.12.04.24317990 — Posted: 2024-12-06
Willingness to pay for COVID-19 vaccine and its correlates: A cross-sectional survey in Bangladesh
Hossain, M. B., Alam, M. Z., Islam, M. S., Sultan, S., Faysal, M. M., Rima, S., Hossain, M. A., Mamun, A. A., Mamun, A.- A.-
10.1101/2024.12.03.24318442 — Posted: 2024-12-06
SARS-CoV-2 predation of Golgi-bound PI4P primes the massive activation of the DNA Damage Response kinase ATM in the cytoplasm
Rebendenne, A., Soulet, C., Valadao, A. L. C., Bonaventure, B., McKellar, J., Moncorge, O., Goujon, C., Moriel-Carretero, M.
10.1101/2024.12.05.626967 — Posted: 2024-12-06
Exploring clinical characteristics of COVID-19 in children and adolescents using a machine-learning approach
Fiandrino, S., Dona, D., Giaquinto, C., Poletti, P., Tira, M. D., Paolotti, D., Di Chiara, C.
10.1101/2024.12.04.24318465 — Posted: 2024-12-06
A Phase II/III, Randomized, double-blind, placebo-controlled trial to evaluate Immunogenicity and Safety of the Gam-COVID-Vac combined vector vaccine in the prophylactic Treatment for SARS-CoV-2 infection in the United Arab Emirates
AlHammadi, A. A., Alzaabi, A. H., Choker, H. B., Ibrahim, A. A., Ishaq, A. B., Mahboub, A. E., Al Dhaheri, R. S., Alzaabi, M. N., Collyns, T. A., ElGhazali, G., Weber, S., al-Ramadi, B. K.
10.1101/2024.11.29.24318199 — Posted: 2024-12-05
Weighted analysis of symptom profile by vaccination status in positive SARS-CoV-2 cases: observational study in Sao Goncalo, Brazil
das Chagas, R. R., Freitas, H. R., Cardozo, S. V.
10.1101/2024.12.03.24318348 — Posted: 2024-12-05
Household clusters of SARS-CoV-2 Omicron subvariants contemporaneously sequenced from dogs and their owners
Ferreira, F. C., Auckland, L., Busselman, R., Davila, E., Tang, W., Lim, A., Sarbo, N., Yaglom, H. D., Centner, H., Mead, H., Tao, Y., Castro, J., Li, Y., Zhang, J., Wang, H., Malapati, L., Cook, P., Retchless, A., Tong, S., Zecca, I., Ghai, R., Barton Behravesh, C., Fischer, R., Hamer, G. L., Hamer, S.
10.1101/2024.12.02.24318339 — Posted: 2024-12-05
Changing parental perceptions to childhood immunisations during the Covid-19 pandemic in the UK: evidence from three cross-sectional surveys between 2020 and 2022
Thistlethwayte, R., de Figueiredo, A.
10.1101/2024.11.29.24318181 — Posted: 2024-12-05
Genome-wide Machine Learning Analysis of Anosmia and Ageusia with COVID-19
Pietan, L., Phillippi, E., Melo, M., El-Shanti, H., Smith, B. J., Darbro, B., Braun, T., Casavant, T.
10.1101/2024.12.04.24318493 — Posted: 2024-12-05
Ubiquitin Ligase ITCH Regulates Life Cycle of SARS-CoV-2 Virus
Xiang, Q., Wouters, C., Chang, P., Lu, Y.-N., Liu, M., Wang, H., Yang, J., Pekosz, A., Zhang, Y., Wang, J.
10.1101/2024.12.04.624804 — Posted: 2024-12-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).